These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11091778)

  • 21. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
    Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
    Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W; Stanley J; Langton D; Kelly Y; Bury G
    Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
    Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS
    PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender.
    Lidman C; Norden L; Kåberg M; Käll K; Franck J; Aleman S; Birk M
    Scand J Infect Dis; 2009; 41(9):679-84. PubMed ID: 19521924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV and HCV testing for young drug users in Rhode Island.
    Pugatch D; Anderson BJ; O'Connell JV; Elson LC; Stein MD
    J Adolesc Health; 2006 Mar; 38(3):302-4. PubMed ID: 16488833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: a cross-sectional study.
    Camoni L; Regine V; Salfa MC; Nicoletti G; Canuzzi P; Magliocchetti N; Rezza G; Suligoi B;
    Scand J Infect Dis; 2009; 41(6-7):520-3. PubMed ID: 19415569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
    Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
    AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users].
    Wang YC; Xu SH; Li XH; Song AJ; Jia XR; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):777-9. PubMed ID: 17299963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India.
    Tripathi AK; Khanna M; Gupta N; Chandra M
    J Assoc Physicians India; 2007 Jun; 55():429-31. PubMed ID: 17879496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to hepatitis B virus and hepatitis C virus in residential detoxification clients in Jamaica.
    Smikle MF; Dowe G; Williams EM; Thesiger C
    Hum Antibodies; 2000; 9(4):231-3. PubMed ID: 11341177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
    Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy.
    Fatseas M; Denis C; Serre F; Dubernet J; Daulouède JP; Auriacombe M
    AIDS Behav; 2012 Oct; 16(7):2082-90. PubMed ID: 21983799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in southwest China.
    Ruan Y; Liang S; Zhu J; Li X; Pan SW; Liu Q; Song B; Wang Q; Xing H; Shao Y
    Sex Transm Dis; 2013 Apr; 40(4):323-8. PubMed ID: 23486498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender differences in HIV risk behaviours among intravenous drug users in Catalonia, Spain.
    Folch C; Casabona J; Espelt A; Majó X; Meroño M; Gonzalez V; Brugal MT;
    Gac Sanit; 2013; 27(4):338-43. PubMed ID: 23578527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut.
    Grau LE; Zhan W; Heimer R
    Drug Alcohol Rev; 2016 Sep; 35(5):628-36. PubMed ID: 27073014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.
    Broers B; Junet C; Bourquin M; Déglon JJ; Perrin L; Hirschel B
    AIDS; 1998 Oct; 12(15):2059-66. PubMed ID: 9814875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection.
    Dickson-Spillmann M; Haug S; Uchtenhagen A; Bruggmann P; Schaub MP
    Eur Addict Res; 2016; 22(4):181-91. PubMed ID: 26656112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.